Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
---|
04/13/2011 | CN102015642A Novel 3-aminoalkyl-1,3-dihydro-2H-indol-2-one derivatives, preparation thereof and therapeutic use thereof |
04/13/2011 | CN102015641A Heterocyclic compound |
04/13/2011 | CN102015639A Compounds for use in stabilizing p53 mutants |
04/13/2011 | CN102015637A Novel phenylpyrrole derivative |
04/13/2011 | CN102015636A Azetidines and cyclobutanes as histamine H3 receptor antagonists |
04/13/2011 | CN102015635A 氮杂环丁烷衍生物 Azetidine derivatives |
04/13/2011 | CN102010520A Triazine light stabilizer containing hindered amine groups |
04/13/2011 | CN102010410A Heterocyclic compound and organic light emitting device including same |
04/13/2011 | CN101384549B Pyrrole derivative or salt thereof |
04/13/2011 | CN101333213B 1-substituted pyridyl-pyrazol acid amide compounds and use thereof |
04/13/2011 | CN101300230B N-(hetero) aryl indole derivatives as pesticides |
04/13/2011 | CN101289425B Enantioselective alkylation of tricyclic compounds |
04/12/2011 | US7923563 Alzheimer's disease, senile dementia, Down syndrome or amyloidosis; 3E)-1-[(1S)-1-(4-fluorophenyl)ethyl]-3-[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)benzylidene]piperidin-2-one; imidazolyl-functional compounds inhibit production of Amyloid beta 40 and Amyloid beta 42; low hygroscopicity; good solubility |
04/12/2011 | US7923556 Phenyl-substituted pyrimidine compounds useful as kinase inhibitors |
04/12/2011 | US7923467 Substituted pyrrole derivatives and their use as HMG-CO inhibitors |
04/12/2011 | US7923461 TNF-α production inhibitors |
04/12/2011 | US7923457 Quinoline derivatives |
04/12/2011 | US7923450 Modulators for amyloid beta |
04/12/2011 | US7923444 Alkyl substituted homopiperazine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
04/12/2011 | US7923129 Carbazole derivative and organic light emitting device using the same |
04/12/2011 | CA2528496C Acylated amino acid amidyl pyrazoles and related compounds |
04/12/2011 | CA2522435C Inhibitors of akt activity |
04/12/2011 | CA2471099C .alpha.-(n-sulphonamido)acetamide derivatives as .beta.-amyloid inhibitors |
04/12/2011 | CA2438427C Method for testing effect of angiogenesis inhibitor via integrin expression inhibition |
04/12/2011 | CA2438304C Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors |
04/12/2011 | CA2426461C Nitrogen-containing aromatic derivatives |
04/07/2011 | WO2011041747A2 Neutral mixed ligand transition metal complexes as active materials in solid-state organic photovoltaic devices |
04/07/2011 | WO2011041655A1 Quinazolin-4-amine derivatives; and methods of use |
04/07/2011 | WO2011041634A1 Pyrazole inhibitors of phosphatidylinositol 3-kinase |
04/07/2011 | WO2011040574A1 Method for producing azetidinylmethoxypyridine derivative and use of azetidinylmethoxypyridine derivative |
04/07/2011 | WO2011040510A1 Indazole analogue |
04/07/2011 | WO2011040004A1 Novel phenylpyridine derivative and medicinal agent comprising same |
04/07/2011 | WO2011039782A1 Processes for preparing imatinib and pharmaceutically acceptable salts thereof |
04/07/2011 | WO2011039528A1 2-pyridone compounds used as inhibitors of neutrophil elastase |
04/07/2011 | WO2011039353A1 New histone deacetylase inhibitors based simultaneously on trisubstituted 1h-pyrroles and aromatic and heteroaromatic spacers |
04/07/2011 | WO2011039290A1 A process for the preparation of trans-(2r)-4-substituted-pipecolic acids and esters thereof, and intermediate compounds used therein |
04/07/2011 | WO2011039130A1 New benzimidazole derivatives and their use as fxr agonists |
04/07/2011 | WO2010135505A3 Crystalline forms of 4-[6-(6-methanesulfonyl-2-methylpyridin-3-ylamino)-5-methoxy-pyrimidin-4-yloxy]-piperidine-1-carboxylic acid isopropyl ester |
04/07/2011 | WO2010130900A3 Triaminopyrimidine derivatives as cdc25 phosphatase inhibitors |
04/07/2011 | WO2010091104A8 Glucosylceramide synthase inhibitors |
04/07/2011 | US20110082299 Method for the preparation of dabigatran |
04/07/2011 | US20110082279 Chemiluminescent Compounds |
04/07/2011 | US20110082175 Insecticidal aryl pyrrolidines |
04/07/2011 | US20110082174 Solid state forms of racemic ilaprazole |
04/07/2011 | US20110082173 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
04/07/2011 | US20110082172 Pyrrolidinone carboxamide derivatives |
04/07/2011 | US20110082165 Pyrrolidine gpr40 modulators |
04/07/2011 | US20110082163 Novel uracil compound or salt thereof having human deoxyuridine triphosphatase inhibitory activity |
04/07/2011 | US20110082155 Novel 2-Pyridone Compounds |
04/07/2011 | US20110082153 Gamma secretase modulators |
04/07/2011 | US20110082152 Therapeutic agents useful for treating pain |
04/07/2011 | US20110082146 Compositions and methods for inhibition of the jak pathway |
04/07/2011 | US20110082144 N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes |
04/07/2011 | US20110082143 Bicyclic Heteroaryl Compounds |
04/07/2011 | US20110082142 Selective kinase inhibitors |
04/07/2011 | US20110082141 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40 |
04/07/2011 | US20110082134 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
04/07/2011 | US20110082133 Pyridone compounds |
04/07/2011 | US20110082130 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues |
04/07/2011 | US20110082129 Organic compounds |
04/07/2011 | US20110081316 Pyrazole inhibitors of phosphatidylinositol 3-kinase |
04/07/2011 | CA2776351A1 New histone deacetylase inhibitors based simultaneously on trisubstituted 1h-pyrroles and aromatic and heteroaromatic spacers |
04/07/2011 | CA2775464A1 Indazole analog |
04/07/2011 | CA2774769A1 Novel compounds that are erk inhibitors |
04/07/2011 | CA2773618A1 2-pyridone compounds used as inhibitors of neutrophil elastase |
04/07/2011 | CA2772815A1 New benzimidazole derivatives and their use as fxr agonists |
04/07/2011 | CA2771338A1 Crystalline hydrochloride salts of c-met kinase inhibitors |
04/06/2011 | EP2305674A1 Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes |
04/06/2011 | EP2305668A1 8-oxy-quinoline derivatives as bradykinin B2 receptor modulators |
04/06/2011 | EP2305667A2 Nilotinib intermediates and preparation thereof |
04/06/2011 | EP2305666A1 Preparation of pyridonecarboxylic acid antibacterials |
04/06/2011 | EP2305665A1 Polymorphs of 3-[(2-{[4-(hexyloxy carbonyl amino-imino-methyl)-phenyl amino]methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propion acid-ethyl ester |
04/06/2011 | EP2305664A1 Anabaseine derivatives useful in the treatment of neurodegeneratives diseases |
04/06/2011 | EP2305663A1 Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and 1-oxoisoindolines and method of reducing TNF alpha levels |
04/06/2011 | EP2305658A1 Novel imino derivative, process for production of the same, and pesticide comprising the same |
04/06/2011 | EP2305655A2 Amino-1,3,5-triazines N-substituted with chiral bicyclic radicals, process for their preparation, compositions thereof, and their use as herbicides and plant growth regulators. |
04/06/2011 | EP2305652A2 Trisubstituted quinazolinone derivatives as vanilloid antagonists |
04/06/2011 | EP2305651A1 2,3,6-trisubstituted-4-pyrimidone derivatives |
04/06/2011 | EP2305647A1 Process for preparing 3-[(4S)-8-bromo-1-methyl-6-(2-pyridinyl)-4 H-imidazo[1,2-a][1,4]benzodiazepine-4-yl] propionic acid methyl ester or the benzene sulfonate salt thereof, and compounds useful in that process |
04/06/2011 | EP2305646A1 A process for the preparation of trans-(2R)-4-substituted-pipecolic acids and esters thereof, and intermediate compounds used therein |
04/06/2011 | EP2305645A1 Aralkyl piperidine derivatives and their uses as antalgic or ataractic agent |
04/06/2011 | EP2305644A1 Aralkyl alcohol piperidine derivative and the use as medicament for treating depression thereof |
04/06/2011 | EP2305643A1 New histone deacetylase inhibitors based simultaneously on trisubstituted 1h-pyrroles and aromatic and heteroaromatic spacers |
04/06/2011 | EP2305259A1 Novel substituted benzimidazole dosage forms and method of using same |
04/06/2011 | EP2305257A1 Amonafide salts and compositions comprising same |
04/06/2011 | EP2305250A1 Benzimidazole derivatives and their use as protein kinases inhibitors |
04/06/2011 | EP2303888A2 Methods and compounds for antimicrobial intervention |
04/06/2011 | EP2303868A2 Stable r(+)-lansoprazole amine salt and a process for preparing the same |
04/06/2011 | EP2303867A1 Pyrazinone modulator of corticotropin-releasing factor receptor activity |
04/06/2011 | EP2303866A2 Crystalline forms of rabeprazole sodium |
04/06/2011 | EP2303865A1 Fungicide hydroximoyl-tetrazole derivatives |
04/06/2011 | EP2303864A1 Fungicide hydroximoyl-tetrazole derivatives |
04/06/2011 | EP2303863A1 5- and 6-membered heterocyclic compounds |
04/06/2011 | EP2303862A2 Wnt protein signalling inhibitors |
04/06/2011 | EP2303861A1 Pyridine compounds |
04/06/2011 | EP2303860A2 2-pyridyl substituted imidazoles as alk4 and/or alk4 inhibitors |
04/06/2011 | EP2303859A2 Aryl gpr119 agonists and uses thereof |
04/06/2011 | EP2303843A2 Fungicidal pyridines |
04/06/2011 | EP2303021A2 Compounds for the treatment of cancer |
04/06/2011 | EP2059518B1 Salts of benzimidazolyl pyridyl ethers and formulations thereof |